BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 15066220)

  • 1. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.
    Leng SH; Lu FE; Xu LJ
    Acta Pharmacol Sin; 2004 Apr; 25(4):496-502. PubMed ID: 15066220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets.
    Liu L; Liu J; Gao Y; Yu X; Xu G; Huang Y
    Br J Pharmacol; 2014 Jul; 171(13):3246-54. PubMed ID: 24588674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinnamic acid exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro.
    Hafizur RM; Hameed A; Shukrana M; Raza SA; Chishti S; Kabir N; Siddiqui RA
    Phytomedicine; 2015 Feb; 22(2):297-300. PubMed ID: 25765836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effects of Huanglian Jiedu decoction on vascular endothelial function in type 2 diabetic rats].
    Xiao YL; Lu FE; Xu LJ; Leng SH; Wang KF
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(22):1767-70. PubMed ID: 16468376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
    Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
    Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
    Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glibenclamide but not other sulphonylureas stimulates release of neuropeptide Y from perifused rat islets and hamster insulinoma cells.
    Kulkarni RN; Wang ZL; Wang RM; Smith DM; Ghatei MA; Bloom SR
    J Endocrinol; 2000 May; 165(2):509-18. PubMed ID: 10810315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A defective stimulus-secretion coupling rather than glucotoxicity mediates the impaired insulin secretion in the mildly diabetic F1 hybrids of GK-Wistar rats.
    Abdel-Halim SM; Ostenson CG; Andersson A; Jansson L; Efendić S
    Diabetes; 1995 Nov; 44(11):1280-4. PubMed ID: 7589824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity.
    Wang ZQ; Lu FE; Leng SH; Fang XS; Chen G; Wang ZS; Dong LP; Yan ZQ
    World J Gastroenterol; 2008 Oct; 14(39):6004-11. PubMed ID: 18932278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extract isolated from Angelica hirsutiflora with insulin secretagogue activity.
    Leu YL; Chen YW; Yang CY; Huang CF; Lin GH; Tsai KS; Yang RS; Liu SH
    J Ethnopharmacol; 2009 Jun; 123(2):208-12. PubMed ID: 19429364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental benefit of moxonidine on glucose metabolism and insulin secretion in the fructose-fed rat.
    Rösen P; Ohly P; Gleichmann H
    J Hypertens Suppl; 1997 Jan; 15(1):S31-8. PubMed ID: 9050983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic rats and mice are resistant to porcine and human insulin: flawed experimental models for testing islet xenografts.
    Pepper AR; Gall C; Mazzuca DM; Melling CW; White DJ
    Xenotransplantation; 2009; 16(6):502-10. PubMed ID: 20042050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1-[4- [2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro.
    Wu GZ; Hong G; Zhang WP; Zhang HB
    Arzneimittelforschung; 2009; 59(11):550-6. PubMed ID: 20066963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models.
    Yao XG; Chen F; Li P; Quan L; Chen J; Yu L; Ding H; Li C; Chen L; Gao Z; Wan P; Hu L; Jiang H; Shen X
    J Ethnopharmacol; 2013 Oct; 150(1):285-97. PubMed ID: 24012527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancreas insulin content in normal rats.
    Chicco A; D'Alessandro ME; Karabatas L; Gutman R; Lombardo YB
    Ann Nutr Metab; 1996; 40(2):61-70. PubMed ID: 8773730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats.
    Tang LQ; Wei W; Chen LM; Liu S
    J Ethnopharmacol; 2006 Nov; 108(1):109-15. PubMed ID: 16759828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of the function of islet beta and alpha cells by intervention against glucotoxicity: experiment with rats].
    He QH; Zhou YS; Wang Z; Wang S; Mou ZQ; Li J; Chi JM
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):374-7. PubMed ID: 18581888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.
    Hamada Y; Ikegami H; Ueda H; Kawaguchi Y; Yamato E; Nojima K; Yamada K; Babaya N; Shibata M; Ogihara T
    Metabolism; 2001 Nov; 50(11):1282-5. PubMed ID: 11699045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.